Draft PA Criteria 2022
Review the Draft PA Criteria for 2022.
Draft PA Criteria January
- Adult Rheumatoid Arthritis Agents (PDF)
- Asthma Agents (PDF)
- Atopic Dermatitis Agents (PDF)
- Enzyme Replacement Therapy (PDF)
- Hepatitis C Agents (PDF)
- Oncology - Auxiliary Treatment Agents (PDF)
- Oncology Agents (PDF)
- Opioid Products Indicated for Pain Management (PDF)
- Systemic Lupus Erythematosus Agents (PDF)
Draft PA Criteria July
- ADHD Medications - Safe Use for All Ages (PDF)
- Atopic Dermatitis Agents (PDF)
- Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Agents (PDF)
- Crohns Disease Agents (PDF)
- High Cost Compounds (PDF)
- Minimum Requirements PA (PDF)
- Oncology - Auxiliary Treatment Agents (PDF)
- Somatropin Products (PDF)
- Ulcerative Colitis Agents (PDF)
Draft PA Criteria October
- Ankylosing Spondylitis Agents (PDF)
- Beta Thalassemia Agents (PDF)
- Enzyme Replacement Therapy (PDF)
- Growth Hormone Agents (previously Somatropin Products)(PDF)
- Minimum Requirements PA (PDF)
- Plaque Psoriasis (PsO) Agents (PDF)
- Spinal Muscular Atrophy (SMA) Agents D (PDF)
- Synagis (PDF)
- Thyroid Eye Disease Agents (PDF)
- Weight Loss Agents (PDF)